Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2002 3
2003 3
2009 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Off-label prescriptions in Italian hospices: a national survey.
Toscani F, Di Giulio P, Campi R, Pellerin I, De Luca A, Casale G; End of Life Observatory Research Group. Toscani F, et al. J Pain Symptom Manage. 2009 Sep;38(3):365-71. doi: 10.1016/j.jpainsymman.2008.11.014. Epub 2009 Jun 28. J Pain Symptom Manage. 2009. PMID: 19564095 Free article.
Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
Cerea G, Vaghi M, Ardizzoia A, Villa S, Bucovec R, Mengo S, Gardani G, Tancini G, Lissoni P. Cerea G, et al. Among authors: mengo s. Anticancer Res. 2003 Mar-Apr;23(2C):1951-4. Anticancer Res. 2003. PMID: 12820485 Clinical Trial.
A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.
Lissoni P, Vaghi M, Ardizzoia A, Malugani F, Fumagalli E, Bordin V, Fumagalli L, Bordoni A, Mengo S, Gardani GS, Tancini G. Lissoni P, et al. Among authors: mengo s. In Vivo. 2002 Mar-Apr;16(2):93-6. In Vivo. 2002. PMID: 12073777 Clinical Trial.
Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group.
Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT; Cancer Pain Outcome Research Study Group (CPOR SG) Investigators; Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F. Apolone G, et al. Clin J Pain. 2009 Oct;25(8):671-82. doi: 10.1097/AJP.0b013e3181a38f9d. Clin J Pain. 2009. PMID: 19920716 Clinical Trial.
Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapy.
Lissoni P, Mengo S, Mandalà M, Mauri E, Brivio F, Rovelli F, Confalonieri G, Longarini R, Bonfante A, Folli D, Meregalli S, Barni S, Tancini G, Giani L. Lissoni P, et al. Among authors: mengo s. J Biol Regul Homeost Agents. 1998 Jan-Jun;12(1-2):38-41. J Biol Regul Homeost Agents. 1998. PMID: 9677534 Clinical Trial.
11 results